Category : Cancer

Cancer

FDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma

rdanielsr6d7
Merck and Eisai today announced that the U.S. Food and Drug Administration (FDA) approved the combination of KEYTRUDA, Merck’s antiPD-1 therapy, plus LENVIMA, the orally...





 

Stay Up-to-Date with Our Weekly "Black Health Matters" Newsletters Straight Into Your Inbox!
SUBSCRIBE!
close-link